South Korea
Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™
ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...
June 07, 2021 | News
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate
Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization, signed a strategic partnership with KAHR...
June 03, 2021 | News
Cytiva acquires GoSilico to to strengthen digital capabilities in bioprocessing
GoSilico's software creates “digital twins” of downstream processes and is increasingly used to enhance process development by simulation Mo...
June 02, 2021 | News
Samsung Biologics to add mRNA vaccine DS production capability
Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its existing facility by the first half of 2022 The addition...
June 01, 2021 | News
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
llumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of So...
June 01, 2021 | News
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.
Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics In...
May 31, 2021 | News
Avance Clinical Releases Industry Survey Results at BIO Korea 2021
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a rec...
May 27, 2021 | News
Multiply Labs Joins forces with Cytiva to automate cell therapy manufacturing.
Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibi...
May 26, 2021 | News
Cytiva and Prestige Biopharma to accelerate manufacturing COVID-19 vaccines and antibody therapies.
Cytiva and Prestige Biopharma have formed a collaboration to accelerate manufacturing COVID-19 vaccines and antibody therapies. With Cytiva’s cell cu...
May 26, 2021 | News
Most COVID-19 Patients Have Long-term Neurological Problems
In a surprise, however, a research team at NYU Grossman School of Medicine also found that 91 percent of patients, whether or not they had a neurological d...
May 25, 2021 | Analysis
Hyundai Bioscience to proceed to clinical trial with CP-COV03
A study on CNPharm's antiviral oral formulation published in a special edition of Pharmaceuticals Hyundai Bioscience (KOSDAQ 048410) announced on ...
May 24, 2021 | News
Moderna and South Korea Explore Collaboration on mRNA Vaccines
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two Memoranda of Unde...
May 24, 2021 | News
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine
Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leadin...
May 24, 2021 | News
'CUVIS-spine' acquired FDA (US) licensing.
'CUVIS-spine' is available in all countries by acquiring the license from the FDA (US), Korea and Europe. 'CUVIS-spine' reduces surgery duration wi...
May 22, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
